Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer
Phase of Trial: Phase III
Latest Information Update: 22 Jul 2017
At a glance
- Drugs Letrozole (Primary) ; Anastrozole
- Indications Early breast cancer
- Focus Registrational; Therapeutic Use
- Acronyms FACE
- Sponsors Novartis
- 23 Jan 2017 Final results published in the Journal of Clinical Oncology.
- 12 Dec 2015 Results presented at the 38th Annual San Antonio Breast Cancer Symposium
- 12 Dec 2015 Primary endpoint "Disease-free survival rate" has not been met, as per the results presented at the 38th Annual San Antonio Breast Cancer Symposium.